Clinical Trial

Salvage HDR for Locally Recurrent Prostate Cancer

Study acronym: PROSALBRA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 21, 2021 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study offers focal salvage brachytherapy for prostate cancer patients with a local recurrence after primary defintive radiotherapy
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-01-13.
Status change: Not Yet Recruiting → Recruiting 2021-07-20
Trial Details
NCT Number NCT04231006
Lead Sponsor Aarhus University Hospital
Conditions Prostate Cancer
Enrollment 50 participants
Start Date 2021-04-01
Primary Completion 2025-03-01 (estimated)
Study Completion 2035-03-01 (estimated)
Updated on ClinicalTrials.gov 2021-07-21